Works by Timme, T. L.

Results: 9

DNA ploidy and clonal selection in ras + myc - Induced mouse prostate cancer.

Published in:

International Journal of Cancer, 1995, v. 60, n. 3, p. 395, doi. 10.1002/ijc.2910600321

By:

Greene, D. R.;
Taylor, S. R.;
Aihara, M.;
Yoshida, K.;
Egawa, S.;
Park, S. H.;
Timme, T. L.;
Yang, G.;
Scardino, P. T.;
Thompson, T. C.

Publication type:

Article

Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.

Published in:

Prostate Cancer & Prostatic Diseases, 2002, v. 5, n. 4, p. 316, doi. 10.1038/sj.pcan.4500610

By:

Ebara, S;
Shimura, S;
Nasu, Y;
Kaku, H;
Kumon, H;
Yang, G;
Wang, J;
Timme, T L;
Aguilar-Cordova, E;
Thompson, T C

Publication type:

Article

Combination gene therapy with adenoviral vector-mediated HSV-tk+GCV and IL-12 in an orthotopic mouse model for prostate cancer.

Published in:

Prostate Cancer & Prostatic Diseases, 2001, v. 4, n. 1, p. 44, doi. 10.1038/sj.pcan.4500494

By:

Nasu, Y;
Bangma, C H;
Hull, G W;
Yang, G;
Wang, J;
Shimura, S;
McCurdy, M A;
Ebara, S;
Lee, H-M;
Timme, T L;
Thompson, T C

Publication type:

Article

Cooperative effects of adenoviral vector-mediated interleukin 12 gene therapy with radiotherapy in a preclinical model of metastatic prostate cancer.

Published in:

Gene Therapy, 2007, v. 14, n. 3, p. 227, doi. 10.1038/sj.gt.3302788

By:

Fujita, T.;
Timme, T. L.;
Tabata, K.;
Naruishi, K.;
Kusaka, N.;
Watanabe, M.;
Abdelfattah, E.;
Zhu, J. X.;
Ren, C.;
Yang, G.;
Goltsov, A.;
Wang, H.;
Vlachaki, M. T.;
Teh, B. S.;
Butler, E. B.;
Thompson, T. C.

Publication type:

Article

Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model.

Published in:

Gene Therapy, 1999, v. 6, n. 3, p. 338, doi. 10.1038/sj.gt.3300834

By:

Nasu, Y;
Bangma, C H;
Hull, G W;
Lee, H-M;
Hu, J;
Wang, J;
McCurdy, M A;
Shimura, S;
Yang, G;
Timme, T L;
Thompson, T C

Publication type:

Article

IL-12 gene-modified bone marrow cell therapy suppresses the development of experimental metastatic prostate cancer.

Published in:

Cancer Gene Therapy, 2007, v. 14, n. 10, p. 819, doi. 10.1038/sj.cgt.7701069

By:

Wang, H.;
Yang, G.;
Timme, T. L.;
Fujita, T.;
Naruishi, K.;
Frolov, A.;
Brenner, M. K.;
Kadmon, D.;
Thompson, T. C.

Publication type:

Article

IL-12 gene-modified bone marrow cell therapy suppresses the development of experimental metastatic prostate cancer.

Published in:

2007

By:

Wang, H.;
Yang, G.;
Timme, T. L.;
Fujita, T.;
Naruishi, K.;
Frolov, A.;
Brenner, M. K.;
Kadmon, D.;
Thompson, T. C.

Publication type:

Correction Notice

Adenoviral vector-mediated RTVP-1 gene-modified tumor cell-based vaccine suppresses the development of experimental prostate cancer.

Published in:

Cancer Gene Therapy, 2006, v. 13, n. 7, p. 658, doi. 10.1038/sj.cgt.7700919

By:

Naruishi, K.;
Timme, T. L.;
Kusaka, N.;
Fujita, T.;
Yang, G.;
Goltsov, A.;
Satoh, T.;
Ji, X.;
Tian, W.;
Abdelfattah, E.;
Men, T.;
Watanabe, M.;
Tabata, K.;
Thompson, T. C.

Publication type:

Article

Therapeutic effects of adoptive splenocyte transfer following in situ AdIL-12 gene therapy in a mouse prostate cancer model.

Published in:

Cancer Gene Therapy, 2006, v. 13, n. 1, p. 91, doi. 10.1038/sj.cgt.7700872

By:

Saika, T.;
Kusaka, N.;
Mouraviev, V.;
Satoh, T.;
Kumon, H.;
Timme, T. L.;
Thompson, T. C.

Publication type:

Article